Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 165

1.

Pregnancy outcome of women exposed to azathioprine during pregnancy.

Goldstein LH, Dolinsky G, Greenberg R, Schaefer C, Cohen-Kerem R, Diav-Citrin O, Malm H, Reuvers-Lodewijks ME, Rost van Tonningen-van Driel MM, Arnon J, Ornoy A, Clementi M, Di Gianantonio E, Koren G, Braunstein R, Berkovitch M.

Birth Defects Res A Clin Mol Teratol. 2007 Oct;79(10):696-701.

PMID:
17847119
2.

Safety of haloperidol and penfluridol in pregnancy: a multicenter, prospective, controlled study.

Diav-Citrin O, Shechtman S, Ornoy S, Arnon J, Schaefer C, Garbis H, Clementi M, Ornoy A.

J Clin Psychiatry. 2005 Mar;66(3):317-22.

PMID:
15766297
3.

Birth outcome in women treated with azathioprine or mercaptopurine during pregnancy: A Danish nationwide cohort study.

Langagergaard V, Pedersen L, Gislum M, Nørgard B, Sørensen HT.

Aliment Pharmacol Ther. 2007 Jan 1;25(1):73-81.

4.

Pregnancy outcome after gestational exposure to terfenadine: A multicenter, prospective controlled study.

Loebstein R, Lalkin A, Addis A, Costa A, Lalkin I, Bonati M, Koren G.

J Allergy Clin Immunol. 1999 Nov;104(5):953-6.

PMID:
10550738
5.

Pregnancy outcome after gestational exposure to metronidazole: a prospective controlled cohort study.

Diav-Citrin O, Shechtman S, Gotteiner T, Arnon J, Ornoy A.

Teratology. 2001 May;63(5):186-92.

PMID:
11320529
6.

Vitamin K antagonists and pregnancy outcome. A multi-centre prospective study.

Schaefer C, Hannemann D, Meister R, Eléfant E, Paulus W, Vial T, Reuvers M, Robert-Gnansia E, Arnon J, De Santis M, Clementi M, Rodriguez-Pinilla E, Dolivo A, Merlob P.

Thromb Haemost. 2006 Jun;95(6):949-57.

PMID:
16732373
7.

Pregnancy outcome of women using atypical antipsychotic drugs: a prospective comparative study.

McKenna K, Koren G, Tetelbaum M, Wilton L, Shakir S, Diav-Citrin O, Levinson A, Zipursky RB, Einarson A.

J Clin Psychiatry. 2005 Apr;66(4):444-9; quiz 546.

PMID:
15816786
8.

Pregnancy outcome after exposure to oral contraceptives during the periconceptional period.

Ahn HK, Choi JS, Han JY, Kim MH, Chung JH, Ryu HM, Kim MY, Yang JH, Koong MK, Nava-Ocampo AA, Koren G.

Hum Exp Toxicol. 2008 Apr;27(4):307-13. doi: 10.1177/0960327108092290.

PMID:
18684801
9.

Azathioprine, mercaptopurine and birth outcome: a population-based cohort study.

Nørgård B, Pedersen L, Fonager K, Rasmussen SN, Sørensen HT.

Aliment Pharmacol Ther. 2003 Mar 15;17(6):827-34.

10.

Minor malformations characteristic of the retinoic acid embryopathy and other birth outcomes in children of women exposed to topical tretinoin during early pregnancy.

Loureiro KD, Kao KK, Jones KL, Alvarado S, Chavez C, Dick L, Felix R, Johnson D, Chambers CD.

Am J Med Genet A. 2005 Jul 15;136(2):117-21.

PMID:
15940677
11.

Pregnancy outcome after gestational exposure to mebendazole: a prospective controlled cohort study.

Diav-Citrin O, Shechtman S, Arnon J, Lubart I, Ornoy A.

Am J Obstet Gynecol. 2003 Jan;188(1):282-5.

PMID:
12548230
12.

Pregnancy outcome following maternal exposure to statins: a multicentre prospective study.

Winterfeld U, Allignol A, Panchaud A, Rothuizen LE, Merlob P, Cuppers-Maarschalkerweerd B, Vial T, Stephens S, Clementi M, De Santis M, Pistelli A, Berlin M, Eleftheriou G, Maňáková E, Buclin T.

BJOG. 2013 Mar;120(4):463-71. doi: 10.1111/1471-0528.12066. Epub 2012 Nov 30.

13.

The safety of calcium channel blockers during pregnancy: a prospective, multicenter, observational study.

Weber-Schoendorfer C, Hannemann D, Meister R, Eléfant E, Cuppers-Maarschalkerweerd B, Arnon J, Vial T, Rodriguez-Pinilla E, Clementi M, Robert-Gnansia E, De Santis M, Malm H, Dolivo A, Schaefer C.

Reprod Toxicol. 2008 Sep;26(1):24-30. doi: 10.1016/j.reprotox.2008.05.065. Epub 2008 Jun 7.

PMID:
18585452
14.

Prenatal exposure to HMG-CoA reductase inhibitors: effects on fetal and neonatal outcomes.

Taguchi N, Rubin ET, Hosokawa A, Choi J, Ying AY, Moretti ME, Koren G, Ito S.

Reprod Toxicol. 2008 Oct;26(2):175-7. doi: 10.1016/j.reprotox.2008.06.009. Epub 2008 Jul 1.

PMID:
18640262
15.

Pregnancy outcome following first-trimester exposure to zopiclone: a prospective controlled cohort study.

Diav-Citrin O, Okotore B, Lucarelli K, Koren G.

Am J Perinatol. 1999;16(4):157-60.

PMID:
10458526
16.

The association between domestic violence during pregnancy and low birth weight or prematurity.

Audi CA, Corrêa AM, Latorre Mdo R, Santiago SM.

J Pediatr (Rio J). 2008 Jan-Feb;84(1):60-7. doi: doi:10.2223/JPED.1744. Epub 2008 Jan 22.

17.

Use of benzodiazepines and benzodiazepine receptor agonists during pregnancy: neonatal outcome and congenital malformations.

Wikner BN, Stiller CO, Bergman U, Asker C, Källén B.

Pharmacoepidemiol Drug Saf. 2007 Nov;16(11):1203-10.

PMID:
17894421
18.

The safety of cetirizine during pregnancy. A prospective observational cohort study.

Weber-Schoendorfer C, Schaefer C.

Reprod Toxicol. 2008 Sep;26(1):19-23. doi: 10.1016/j.reprotox.2008.05.053. Epub 2008 May 13.

PMID:
18571373
19.

Use of glargine in pregnant women with type 1 diabetes mellitus: a case-control study.

Imbergamo MP, Amato MC, Sciortino G, Gambina M, Accidenti M, Criscimanna A, Giordano C, Galluzzo A.

Clin Ther. 2008 Aug;30(8):1476-84. doi: 10.1016/j.clinthera.2008.08.013.

PMID:
18803989
20.

Pregnancy outcome after gestational exposure to loratadine or antihistamines: a prospective controlled cohort study.

Diav-Citrin O, Shechtman S, Aharonovich A, Moerman L, Arnon J, Wajnberg R, Ornoy A.

J Allergy Clin Immunol. 2003 Jun;111(6):1239-43.

PMID:
12789223

Supplemental Content

Support Center